| Related Articles |
Sy20-3promising pharmacological agents for internet addiction.
Alcohol Alcohol. 2014 Sep;49 Suppl 1:i19
Authors: Roh SW
Abstract
Since the Internet appeared, it has, in turn, led to the emergence of psychopathological features of addiction linked to its use. To date, however, there is no standard clinical treatment protocols or approved medications. There have been many reports suggesting Internet addiction has a high comorbidity with various psychiatric disorders such as attention-deficit/hyperactivity disorder (ADHD), depression, social phobia, and so on. The use of an opioid receptor antagonist could be considered for patients with high levels of discomfort and craving, and substance use disorders. For patients with depression or anxiety disorders, selective serotonin reuptake inhibitors could be helpful. Bupropion could be also helpful to patients with major depressive disorder. If the patients have manic, hypomanic, or excitement symptoms, the clinicians could consider the use of mood stabilizers. Psychostimulants and atypical antipsychotics could benefit Internet-addicted patients aiming to impulsivity/compulsivity and ADHD symptoms respectively. Although a clinically significant beneficial effect is easily observed, it is difficult to determine to what extent pharmacological treatment of concurrent mental disorders may affect the psychopathology related to Internet addiction. Further randomized controlled trials with long-term follow-up will be required to evaluate the treatment effects in large samples of Internet addiction.
PMID: 25221037 [PubMed – in process]
